Aspenol Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.55 Cr
- Paid Up Capital ₹ 5.36 M
- Company Age 28 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.80 Cr
- Satisfied Charges ₹ 4.91 Cr
- Revenue Growth -13.57%
- Profit Growth -34.25%
- Ebitda -23.86%
- Net Worth 29.13%
- Total Assets -21.07%
About Aspenol Biosciences
Aspenol Biosciences Private Limited (ABPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 September 1996 and has a history of 28 years and four months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Aspenol Specialities Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.55 Cr and a paid-up capital of Rs 5.36 M.
The company currently has active open charges totaling ₹4.80 Cr. The company has closed loans amounting to ₹4.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajaykumar Pasrasrampuria and Shilpa Parasrampuria serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51410GJ1996PTC030749
- Company No.
030749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Aspenol Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajaykumar Pasrasrampuria  | Director | 19-Sep-1996 | Current |
| Shilpa Parasrampuria | Director | 21-Mar-1998 | Current |
Financial Performance of Aspenol Biosciences.
Aspenol Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.57% decrease. The company also saw a substantial fall in profitability, with a 34.25% decrease in profit. The company's net worth Soared by an impressive increase of 29.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aspenol Biosciences?
In 2022, Aspenol Biosciences had a promoter holding of 99.17% and a public holding of 0.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.80 Cr
₹4.91 Cr
Charges Breakdown by Lending Institutions
- Others : 4.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Aug 2023 | Others | ₹4.25 Cr | Open |
| 10 Aug 2023 | Others | ₹3.70 M | Open |
| 10 Aug 2023 | Others | ₹1.80 M | Open |
| 20 Dec 2021 | Others | ₹3.70 M | Satisfied |
| 06 Jun 2020 | Others | ₹5.90 M | Satisfied |
How Many Employees Work at Aspenol Biosciences?
Unlock and access historical data on people associated with Aspenol Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aspenol Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspenol Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
